BD ups earnings target with strong Q3 bottom-line
This article was originally published in Clinica
Executive Summary
A 2% drop in revenues did not stop BD from recording strong bottom-line growth of around 15% for the third fiscal quarter. The Franklin Lakes, New Jersey-based company posted sales of $1.8bn, aided by its diagnostics business which made $566m, a 2% increase compared to the same period last year.